Triumph Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
SC
ONB
GIM
WAM
CRM
Triumph Capital Management's LLY Position: Q2 2026 in Review
Triumph Capital Management increased its Eli Lilly (LLY) stake by 28% in Q2 2026, buying an estimated $688K and bringing the position to 3,038 shares worth $3.64M. The position accounts for 0.66% of the portfolio, ranked #34.
Triumph Capital Management first reported a position in LLY in Q3 2021 and has held it in 18 quarters since. 1,063 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Triumph Capital Management held 3,038 shares of Eli Lilly worth $3.64M as of Q2 2026.
- Triumph Capital Management bought 673 Eli Lilly shares in Q2 2026, an estimated $688K.
- Eli Lilly made up 0.66% of Triumph Capital Management's portfolio in Q2 2026, its #34 holding.
- Triumph Capital Management first reported a position in Eli Lilly in Q3 2021 and has held it in 18 quarters since.
- 1,063 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Triumph Capital Management's 13F filing for Q2 2026, filed 21 Jul 2026.